Type 1 diabetes affects millions of people globally and requires careful management to
avoid serious long-term complications, including heart and kidney disease, stroke, and loss …

Mesenchymal stem cells (MSCs) are self-renewing multipotent cells that have the capacity to
secrete multiple biologic factors that can restore and repair injured tissues. Preclinical and …

Accumulating evidence indicates that most primary Wharton's jelly mesenchymal stem cells
(WJ-MSCs) therapeutic potential is due to their paracrine activity, ie, their ability to modulate …

During the past decade, mesenchymal stem cells (MSCs) have made their mark as a
potential weapon in regenerative medicine. Since their first isolation by Friedenstein in the …

Background Stem cell therapy provides great hope for patients with diabetes mellitus (DM).
DM is a seriously alarming metabolic disease characterized by hyperglycemia and β cell …

Diabetes mellitus (DM) is an alarming metabolic disease in which insulin secreting β-cells
are damaged to various extent. Unfortunately, although currently available treatments help …

Progestins are a broad class of progestational agents widely differing in their chemical
structures and pharmacological properties. Despite emerging data suggest that progestins …

Diabetes mellitus (DM), a chronic disorder of carbohydrate metabolism, is characterized by
the unbridled hyperglycemia resulted from the impaired ability of the body to either produce …

Severe intraventricular hemorrhage (IVH) remains a major cause of high mortality and
morbidity in extremely preterm infants. Mesenchymal stem cell (MSC) transplantation is a …

Diabetes mellitus is a disease which has affected 415 million patients in 2015. In an effort to
replace the significant demands on transplantation and morbidity associated with …